NDC 55513-078 – Imlygic

Talimogene Laherparepvec 1000000 [PFU]/mL · Injection, Suspension · Intralesional

Human Prescription Drug

Product NDC55513-078

Product details

Brand name
Imlygic
Generic name
Talimogene laherparepvec
Labeler
Amgen Inc
Dosage form
Injection, Suspension
Route
Intralesional
Marketing category
BLA · BLA125518
Marketed since
November 2, 2015
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Imlygic →

Package NDC codes (1)

Package NDCDescriptionSince
55513-078-011 VIAL in 1 CARTON (55513-078-01) / 1 mL in 1 VIALNov 2, 2015

Other Imlygic products